Pembrolizumab for treatment-refractory metastatic castration-resistant prostate cancer: Multicohort, open-label phase II KEYNOTE-199 study

ES Antonarakis, JM Piulats, M Gross-Goupil, J Goh, K Ojamaa, CJ Hoimes, U Vaishampayan, R Berger, A Sezer, T Alanko, Ronald de Wit, C Li, A Omlin, G Procopio, S Fukasawa, KI Tabata, SH Park, S Feyerabend, C G Drake, H WuP Qiu, J Kim, C Poehlein, JS de Bono

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)395-405
Number of pages11
JournalJournal of Clinical Oncology
Volume38
DOIs
Publication statusPublished - 2020

Cite this